Lysosomal Acid Lipase Deficiency - 25 Studies Found
No longer available |
: An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency : Lysosomal Acid Lipase Deficiency : 2015-02-25 : Drug: sebelipase alfa Other Name: SBC-102, recombinant human lysosomal acid lipase, rhLAL |
Active, not recruiting |
: Screening for Lysosomal Acid Lipase Deficiency : Lysosomal Acid Lipase Deficiency : 2016-10-04 : Other: There is no intervention in the study |
Active, not recruiting |
: Safety and Efficacy Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency : Lysosomal Acid Lipase Deficiency : 2014-03-20 : Drug: sebelipase alfa Intravenous infusion of sebelipase alfa: 1mg/kg every other week |
Active, not recruiting |
: Clinical Trial in Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency : Lysosomal Acid Lipase Deficiency : 2014-07-07 : Drug: sebelipase alfa Sebelipase alfa is a recombinant human lysosomal acid lipase (rhLAL). The investig |
Completed |
: A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype :
|
Terminated |
: Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102 :
|
Active, not recruiting |
: SurVival of Lysosomal Acid Lipase Deficiency (LAL-D) Infants Treated With SebelipAse aLfa :
|
Active, not recruiting |
: Identification of Undiagnosed Lysosomal Acid Lipase Deficiency :
|
Active, not recruiting |
: A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy) :
|
Completed |
: Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Patients With Lysosomal Acid Lipase Deficiency :
|